Innate Pharma (IPH) — Net Asset Momentum
Innate Pharma (IPH) recorded a net asset momentum of -345.7% as of December 2025, with net assets of €-21.70 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can Innate Pharma fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Innate Pharma Net Asset Momentum (2003–2025)
This chart tracks Innate Pharma's year-over-year net asset growth across 23 annual reporting periods from 2003 to 2025. The most recent momentum reading is -345.7%, with net assets of €-21.70 Million EUR as of December 2025. Read Innate Pharma balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Innate Pharma (2003–2025)
The table below shows the complete annual net asset history for Innate Pharma from 2003 to 2025, covering 23 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see IPH market cap.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €-21.70 Million | €62.72 Million | €84.42 Million | ▼ -345.7% |
| 2024 | €8.83 Million | €111.06 Million | €102.22 Million | ▼ -83.0% |
| 2023 | €51.90 Million | €184.19 Million | €132.29 Million | ▼ -4.2% |
| 2022 | €54.15 Million | €207.86 Million | €153.71 Million | ▼ -49.6% |
| 2021 | €107.44 Million | €267.50 Million | €160.06 Million | ▼ -31.1% |
| 2020 | €155.97 Million | €307.42 Million | €151.45 Million | ▼ -28.3% |
| 2019 | €217.42 Million | €401.36 Million | €183.94 Million | ▲ +30.0% |
| 2018 | €167.24 Million | €451.22 Million | €283.98 Million | ▲ +94.6% |
| 2017 | €85.96 Million | €255.02 Million | €169.07 Million | ▼ -0.2% |
| 2016 | €86.17 Million | €281.58 Million | €195.41 Million | ▲ +19.6% |
| 2015 | €72.07 Million | €305.96 Million | €233.89 Million | ▼ -3.4% |
| 2014 | €74.63 Million | €90.69 Million | €16.06 Million | ▲ +85.2% |
| 2013 | €40.29 Million | €55.88 Million | €15.60 Million | ▲ +72.4% |
| 2012 | €23.36 Million | €48.30 Million | €24.93 Million | ▼ -12.2% |
| 2011 | €26.62 Million | €60.11 Million | €33.48 Million | ▼ -20.6% |
| 2010 | €33.52 Million | €48.01 Million | €14.49 Million | ▼ -28.9% |
| 2009 | €47.12 Million | €64.22 Million | €17.10 Million | ▲ +14.0% |
| 2008 | €41.34 Million | €60.86 Million | €19.52 Million | ▼ -16.7% |
| 2007 | €49.61 Million | €63.15 Million | €13.55 Million | ▼ -12.0% |
| 2006 | €56.37 Million | €69.25 Million | €12.89 Million | ▲ +180.9% |
| 2005 | €20.07 Million | €24.77 Million | €4.70 Million | ▼ -19.8% |
| 2004 | €25.01 Million | €29.51 Million | €4.50 Million | ▲ +65.6% |
| 2003 | €15.11 Million | €20.38 Million | €5.27 Million | — |